Concepedia

K. C. Turner

KC

31

Publications

3.4K

Citations

21

H-Index

1977

Active since

Affiliations

Regeneron (United States)(Current)

University of North Carolina at Chapel Hill

Fred Hutch Cancer Center

National Institutes of Health

University of Washington

K. C. Turner is an author at Regeneron (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1977–2025

31

Publications

31

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

David M. Weinreich, Sumathi Sivapalasingam, Thomas Norton et al. · New England Journal of Medicine · 2020 · 1.8K citations · Full text

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

Meagan P. O’Brien, Eduardo Forleo‐Neto, Bret J. Musser et al. · New England Journal of Medicine · 2021 · 470 citations · Full text

Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study

Peter Lawlor, K. C. Turner, John Hanson et al. · Pain · 1997 · 147 citations

, , +18

Altered Hepatobiliary Disposition of Acetaminophen Glucuronide in Isolated Perfused Livers from Multidrug Resistance-Associated Protein 2-Deficient TR− Rats

Hao Xiong, K. C. Turner, E. Stacy Ward et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 119 citations

US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials

Jeanne M. Regnante, Nicole Richie, Lola A. Fashoyin‐Aje et al. · Journal of Oncology Practice · 2019 · 93 citations · Full text

Rows per page

1–5 of 31